Anti-breast Cancer Agents, Quinolines, Targeting Gap Junction

E-ISSN： 1875-6638|7|5|448-453

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.5, 2011-01, pp. : 448-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 4, 2018-01 ,pp. : 369-379

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Evaluation of Estradiol Derivatives as Anti-Breast Cancer Agents

Letters in Drug Design & Discovery, Vol. 7, Iss. 6, 2010-07 ,pp. : 389-394

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Breast Cancer Agents from Chinese Herbal Medicines

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 101-105

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2- Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents

Letters in Drug Design & Discovery, Vol. 13, Iss. 1, 2015-10 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

Hormone-related pharmacokinetic variations associated with anti-breast cancer drugs

By Li Juan

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite